Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M115Revenue (TTM) $M119Net Margin (%)-39.1Altman Z-Score-4.2
Enterprise Value $M22.3EPS (TTM) $-1.0Operating Margin %-39.5Piotroski F-Score3
P/E(ttm)--Beneish M-Score-4.3Pre-tax Margin (%)-39.2Higher ROA y-yY
Price/Book1.110-y EBITDA Growth Rate %--Quick Ratio4.8Cash flow > EarningsN
Price/Sales4.15-y EBITDA Growth Rate %-13.0Current Ratio4.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-19.3Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-46.1Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M49.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with INFI

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

INFI is held by these investors:



INFI: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BIOTECHNOLOGY VALUE FUND L P10% Owner 2017-01-03Buy4,379$1.3472.39view
BIOTECHNOLOGY VALUE FUND L P10% Owner 2016-12-30Buy742,401$1.3472.39view
BIOTECHNOLOGY VALUE FUND L P10% Owner 2016-12-20Buy654,921$1.3176.34view
KANGO SUJAYChief Commercial Officer 2016-12-13Sell75,000$1.2880.47view
BIOTECHNOLOGY VALUE FUND L P10% Owner 2016-12-02Buy201,394$1.1994.12view
Perkins Adelene QPresident & CEO 2015-06-25Sell5,000$10.93-78.87view
Palombella Vito J.Chief Scientific Officer 2015-06-15Sell4,737$10.97-78.94view
Perkins Adelene QPresident & CEO 2015-05-27Sell10,000$12.81-81.97view
Perkins Adelene QPresident & CEO 2015-05-14Sell10,000$12.18-81.03view
Perkins Adelene QPresident & CEO 2015-03-16Sell20,000$16-85.56view

Quarterly/Annual Reports about INFI:

News about INFI:

Articles On GuruFocus.com
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q/A) Mar 15 2011 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 04 2010 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) May 06 2010 
INFINITY PHARMACEUTICALS, INC. Reports Operating Results (10-Q) Aug 06 2009 
Infinity Pharmaceuticals Inc. Reports Operating Results (10-Q) May 06 2009 

More From Other Websites
Infinity Announces Promotion of Jeffery Kutok, M.D., Ph.D. to Chief Scientific Officer Feb 13 2017
Infinity to Present at the 2017 BIO CEO & Investor Conference Feb 06 2017
Faster FDA Approval Process Could Ignite These Biotech Stocks in 2017 Feb 02 2017
Infinity Presents Preclinical Data and Phase 1 Clinical Data on IPI-549 at PI3K Keystone Symposia... Jan 20 2017
INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 09 2017
Infinity Provides 2017 Goals and Financial Guidance Jan 09 2017
Don't Tell Anyone: Insiders Are Buying These Stocks Like Crazy Jan 08 2017
Infinity To Present At 35th Annual J.P. Morgan Annual Healthcare Conference Jan 05 2017
Infinity Announces Organizational Changes Jan 04 2017
INFINITY PHARMACEUTICALS, INC. Files SEC form 8-K, Change in Directors or Principal Officers Jan 04 2017
Infinity Announces Organizational Changes Jan 04 2017
5 Stocks Insiders Love Right Now Dec 21 2016
How Health Insurance Innovations Inc (HIIQ) Stacks Up Against Its Peers Dec 19 2016
Is Infinity Pharmaceuticals Inc. (INFI) a Good Stock to Buy? Dec 10 2016
INFINITY PHARMACEUTICALS, INC. Financials Nov 17 2016
Infinis plc announces second quarter results for year ending 31.03.17 £350m 7% Senior Notes due... Nov 16 2016
Infinity (INFI) Reports Narrower-than-Expected Loss in Q3 Nov 11 2016
Bristol-Myers Squibb Company (BMY), Infinity Pharmaceuticals, Inc. (INFI) Team Up On Opdivo... Nov 10 2016
Blog Coverage Bristol-Myers Squibb and Infinity Pharma Collaborate for Clinical Trials to Test... Nov 10 2016
Edited Transcript of INFI earnings conference call or presentation 9-Nov-16 9:30pm GMT Nov 09 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)